Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 8953
TargetCasein kinase II subunit alpha'(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 431900BDBM431900(US10550125, Example 4)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent

TargetCasein kinase II subunit alpha'(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 431891BDBM431891(US10550125, Example 1)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 431891BDBM431891(US10550125, Example 1)
Affinity DataIC50: 10nMAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent

TargetCasein kinase II subunit alpha'(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 431907BDBM431907(US10550125, Example 5)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent

TargetCasein kinase II subunit alpha'(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 431893BDBM431893(US10550125, Example 3)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 431900BDBM431900(US10550125, Example 4)
Affinity DataIC50: 55nMAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent

TargetCasein kinase II subunit alpha'(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 431892BDBM431892(US10550125, Example 2)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 431907BDBM431907(US10550125, Example 5)
Affinity DataIC50: 550nMAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 431893BDBM431893(US10550125, Example 3)
Affinity DataIC50: 550nMAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 431892BDBM431892(US10550125, Example 2)
Affinity DataIC50: 550nMAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent